This round is no longer accepting investments, but hundreds just like it are live now.



Move Pain-Free: FDA-Cleared laser therapy at home

Kineon is a biotech company that is dedicated to changing the way we approach chronic pain, through next-generation light therapy products.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

$502,370.31 Raised


Kineon is seeking to redefine light therapy with their next-generation laser device, the MOVE+ – a safe, effective, and affordable solution to treat joint pain and inflammation in as little as 5 minutes.

Kineon is tackling the $142.5B chronic pain market. 9K units sold (September '22 to July '23), $3.5M sales value (August '22 to June '23); monthly revenue growth from $80K to $400K in 10 months. We previously raised $1.35M on Indiegogo.*

With hundreds of glowing reviews on Trustpilot and endorsements from world-class athletes, the MOVE+ is fast-growing a loyal fan base of users worldwide.

*Source | Source

the pitch

Illuminating Lives & Transforming Health

Kineon began with a core mission to empower the largest number of people in the most impactful way, to take ownership of their health and quality of life. 

Our light therapy devices provide an effective alternative approach to pharmaceuticals – providing not a band-aid solution, but a genuine shift in how we approach pain relief.

With FDA clearance, 9,000+ units sold, and $3.5M+ in sales, we believe Kineon is quickly becoming one of the most effective solutions for chronic pain on the market.

The Problem & Our solution

The Chronic Pain Epidemic

Chronic pain is a debilitating condition that affects over 20% of adults in the United States, and severely impacts the lives of millions of people every day.

For too long, the answer to chronic pain has been temporary and costly solutions, such as pharmaceuticals, that simply mask the pain without addressing the root cause.

These solutions are not only ineffective but also carry harmful side effects, leaving people trapped in a cycle of pain long-term.

To date, there are now over 6,000 clinical studies showing the benefits of light therapy for a huge variety of conditions, including acute injuries (MCL, ACL, meniscus tear or sprain) as well as inflammatory conditions like osteoarthritis, rheumatoid arthritis, tendinitis, and gout (Source).

Laser therapy has also proven to be very effective post-surgery to speed up recovery (Source | Source).

Affordable At-Home Laser Therapy

Traditional laser therapy devices can cost upwards of $15,000, making them inaccessible to many (Source). Meanwhile, most home-use devices rely solely on LED technology, lacking the penetrating power required for effective tissue targeting. 

Alternatives to laser therapy devices typically include costly surgeries, reliance on pharmaceutical drugs, or outdated R.I.C.E methods. 

That's why Kineon developed MOVE+ Pro: the next-generation laser therapy device that tackles chronic pain head-on in as little as 5 minutes. 

Unlike costly clinical treatments or ineffective home-use devices, MOVE+ Pro bridges the accessibility gap by offering sub-$500 pricing, optimal dosing, and a simple user experience. MOVE+ Pro works by combining LEDs and lasers in a narrower emission field, penetrating deep into the body for optimal dosing. 

Our wearable device works in direct contact with the skin, ensuring consistent and effective treatment. With MOVE+ Pro, individuals can manage their pain and inflammation at home, and take control over their health and quality of life.

the market & Our Traction

Bringing Light Therapy Home & Beyond

For decades, the potential of light therapy has been hindered by complex dosing and prohibitive costs. However, the correct dosing has required testing to optimize and the cost to produce laser devices has made it prohibitive for home use until the last 3 years. 

Our target market, the chronic pain market is expected to reach $142.5B by 2033 (Source). But thanks to recent advancements in VCSEL lasers, Kineon has created MOVE+, a battery-driven, wearable system that brings the power of light therapy into the comfort of your home. 

The market has responded with enthusiasm, as evidenced by our growth, delivering over 9,000 devices worldwide within just 9 months, increasing our monthly revenue to $400K. From September 2022 to May 2023, we saw our sales increase from $80K to $400K. As a consequence, our COGS experienced an increase from $13,452 to $63,784.

*The above testimonials may not be representative of the opinions or of the experiences of other users and is not a guarantee of future performance or success.

The MOVE+ has been endorsed by world-renowned athletes, medical professionals, and biohackers who are getting incredible results, and sharing their journey with millions of people all over the world.

We've partnered with athletes from 6 renowned professional sports leagues including the NFL, Soccer, CrossFit, NBA, MLB, and Rugby, earning support from elite athletes like Sara Sigmundsdottir and Brooke Wells (both Crossfit Games Athletes with 1.8M+ IG followers). 

*The above testimonials may not be representative of the opinions or of the experiences of other professional athletes and users and is not a guarantee of future performance or success.

With the medical community's overwhelming support, we've been able to launch a Medical Practitioner Reseller (MPR) program to better reach those who need our product the most.

Our operations have received FDA and FCC clearances, and we've continued to develop and scale our U.S. and ROW warehouses to streamline shipments. 

We've already designed and shipped multiple product upgrades since August 2022, and we're now preparing to launch our next cutting-edge product, the Gut+ later this year. This device can be a huge step forward in supporting common gut health-related issues, like IBS, Crohn's and Colitis.

Our next anticipated game-changer, the Brain+, is in the works, which aims to treat a range of common cognitive disorders like anxiety, depression, PTSD, Alzheimer's, and dementia.

*This is a rendering of GUT+ and BRAIN+. Images are computer-generated demo versions. The products are still currently under development and are not yet available on the market.

We aim to expand our reach from the medical community and professional sports leagues, to beyond, transforming lives, one MOVE+ at a time.

Why Invest

Join the MOVE+ment

MOVE+ Pro, is a portable solution designed to deliver clinical dosing with ease and precision, to improve the quality of life for those that need it most. 

With world-class laser therapy devices that offer an effective alternative to pharmaceuticals, Kineon is transforming the landscape of red light therapy. 

We believe our monthly revenue growth from $80,000 to $400,000 in 9 months speaks volumes about the demand for our innovative solutions. 

Supported by FDA clearance and a previous Indiegogo campaign that raised $1.35 million, Kineon is backed by a strong community of users. Glowing reviews and endorsements from professional athletes and leagues further underscore our credibility. 

By investing in Kineon, you're not only supporting our mission to develop revolutionary devices, but also investing in a world where pain relief is accessible and life-changing for everyone.

We're inviting you to be a part of this journey and share in the success of a product that is transforming the way we approach chronic pain. 


4840 Rebel Trail
Atlanta, GA 30327

Kineon is a biotech company that is dedicated to changing the way we approach chronic pain, through next-generation light therapy products.


Forrest Smith
Forrest Smith
Chief Executive Officer, Co-Founder, Board Member
Forrest studied Chinese from the age of 14 and was fascinated with the culture from a very young age. Forrest is fluent in Chinese and has 18 years of experience in successful startup building and executive management in Asia. In 2000, Forrest started his first venture in China, a fabric sourcing company that was acquired in 2002. Over his next ten years in China, Forrest founded and managed multiple ventures from startup to acquisition, including Source Pro Asia (a small sourcing company, August Vale (tannery, leather furniture company acquired by Wilway Holdings), and most recently Illumitron (LED lighting and controls, company acquired by Cooper Lighting). 

Aside from his founder position in multiple companies, Forrest has held several positions, from Director of Asian Operations for a Fortune 500 company to Director of Business Development. His education includes International Baccalaureate with a focus on Chinese, Nanjing University/Johns Hopkins Center, and Georgia Tech. 

Thomas Sanderson
Thomas Sanderson
Chief Operating Officer, Co-Founder, Board Member
Tom Sanderson is the COO of Kineon. An entrepreneur at heart, driven by a passion for human health and well-being, Tom has worked in international startups for more than 16 years. Born in Bahrain and raised in the North of England.

Over 10 years as co-founder of a successful Film Production Studio based out of South East China - providing film services for leading global brands such as Huawei, Sennheiser, Audi, John Lewis...

He firmly believes that incorporating mindfulness, health and well-being into your professional and personal life is the key to success.

Edward Sanderson

Edward Sanderson

Chief Financial Officer, Board Member

Fellow of the Institute of Chartered Management Accountants. Ed has worked in the UK, Europe and the Middle East providing Board level Financial support over many years.


Nov. 16, 2023 at 7:59 AM UTC
$15k - $1.24M
Common Stock
Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Most Recent Fiscal Year-End

Prior Fiscal Year-End

Total Assets



Cash & Cash Equivalents



Accounts Receivable



Short-Term Debt



Long-Term Debt



Revenue & Sales



Costs of Goods Sold



Taxes Paid



Net Income



*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below. 

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

Investment Incentives & Bonuses*

Time-Based Perks

Super Early Bird - Invest within the first 72 hrs and receive 10% bonus shares

Early Bird - Invest within the first two weeks and receive 5% bonus shares 

Combo Perks

Avid Investor - Invest $2.5K (or more) in the first two weeks and receive 15% bonus shares

Volume-Based Perks

Tier 1 Perk — Invest $1,000 and receive 2% bonus shares

Tier 2 Perk — Invest $2,500 and receive 3% bonus shares plus 1 Move+ Pro device

Tier 3 Perk — Invest $5,000 and receive 5% bonus shares, 1 Move+ Pro device, 1 Gut+ device

Tier 4 Perk — Invest $10,000 and receive 10% bonus shares, 1 Move+ Pro device, 1 Gut+ device

Tier 5 Perk — Invest $25,000 and receive 15% bonus shares, 1 Move+ Pro device, 1 Gut+ device and join VIP shareholder update

Tier 6 Perk — Invest $50,000 and receive 20% bonus shares, 1 Move+ Pro device, 1 Gut+ device, 1 Brain+ device, join VIP shareholder update and personal CEO updates

Flash Perks

Flash Perk 1 — Invest $5,000 between 9am PST September 8th to 9am PST September 11th and receive 10% bonus shares

Flash Perk 2 — Invest $5,000 between 9am PST October 8th to 9am PST October 11th and receive 10% bonus shares

Loyalty Bonus

Reservation Holders in the Testing the Waters Page, previous investors, friends and family will receive 10% bonus shares.

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.

Crowdfunding investments made through a self-directed IRA cannot receive non-bonus share perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those non-bonus share perks because they would be receiving a benefit from their IRA account.

The 10% StartEngine Owners' Bonus

Kineon, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $1.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $100. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus and the 10% Loyalty Bonus in addition to the aforementioned bonus.

Irregular Use of Proceeds

Example - The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.


Article Image
AP News

Kineon Launches Start Engine Equity Crowdfunding Campaign

Article Image
New Atlas

Find Freedom From Joint Pain With The Kineon Move+

Article Image

Knee Pain Relief: Discover How Red Light Therapy at Home Eases Inflammation and Discomfort

Article Image
Morning Chalk Up

How Does Kineon's Light Therapy Device Work? The Science Behind The Tool Elite CrossFitters Swear By

Article Image
Yanko Design

Reduce and Heal Chronic Joint Pain With The World's First Wearable 'Pain Killer'



Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into Kineon.


Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

Owners bonus

Owner’s Bonus

Owner’s Bonus Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).



William Coulter

3 months ago

Hey!, I didn't see in the info what wavelength your equipment produces. I'm considering it for my wife's use and my investment. Is it in the 600-825nm range? Thank you,



Léa Bouhelier-Gautreau

3 months ago

Hi! Could you please tell us your burn rate and your cash on hand?



Sherwood Neiss

3 months ago

Hello Kineon Team, I represent D3VC, a venture fund that specializes in equity crowdfunding deals. We’ve taken a keen interest in your offering on StartEngine. As part of our due diligence process, we have a couple of questions: With the ever-evolving landscape of your industry, how does Kineon plan to differentiate itself from existing competitors and maintain a competitive edge? We’re curious about your distribution strategy. Could you shed some light on where you intend to perform distribution and any partnerships or channels you’re considering? We appreciate your time and look forward to understanding more about your venture.



Michael Deuker

3 months ago

Are you allowed to tell us which pro athletes have endorsed or backed your product?



Jorge Filevich

3 months ago

Where is the clinical trials that you talk about? Can you provide copies of the publications?



Grigore Hreniuc

4 months ago

There are tons of infrared lights therapy for pain relief on Ebay, Amazon.. sells for $25-$100. What's makes your device different?



Leonard Borusky

4 months ago

Is there a timeline for releasing future projects such as the Gut+? When can we expect to see those projects hit market?



W Kim Colich

4 months ago

Hi, Does Kineon have any Patents secured for this technology? Thanks. Blessings




Cancel anytime before 48 hours before a rolling close or the offering end date.



We want you to succeed and get the most out of your money by offering rewards and memberships!


Your info is your info. We take pride in keeping it that way!


Invest in over 200 start-ups and collectibles!


With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.


Get To Know Us

Our Team



Important Message

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA / SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

Investment opportunities posted and accessible through the site are of three types:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information

(800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to

StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine.

None of the information displayed on or downloadable from (the any security. It also does not constitute an offer to provide investment advice or service. any security. It also does not constitute an offer to provide investment advice or service. any security. It also does not constitute an offer to provide investment advice or service. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, or (2) assist in the determination of fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.

All investment opportunities are based on indicated interest from sellers and will need to be confirmed.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC. (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC. (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.